BIO.VI Biogena Group Invest AG

Consumer Defensive Packaged Foods Vienna Exchange
4.96 EUR
Close of Oct 29, 2026
2.77 5.95
Market cap
EUR 19.8M
P/E
70.9x
P/B
2.26x
ROE
3.3%
Dividend yield
1.01%
Fundamental score
1.8/5

Ratios use the latest price and the fiscal year ending Jan 2026.

Is BIO.VI undervalued?

Graham number
Price4.96
Graham value1.86
Premium166.7%

BIO.VI trades 166.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Biogena Group Invest AG fundamental analysis

8 of 22 checks passed

ROE 0/2

Low return on equity (3.3%), below 10%.

ROA 1/1

Return on assets (3.3%) is above the industry median (2.7%).

Profit Consistency 2/2

Profitable for 6 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-11.2%) is not above the 5-year average (4.7% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (-11.2%) is above the industry median (-17.0%).

Revenue Growth 2/2

Revenue grew 11.8% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 29,685,503.0x against interest expense, well covered.

PE vs Market 0/1

PE (70.9x) is above the market median (18.5x).

PE vs Industry 0/1

PE (70.9x) is above the industry median (10.5x).

PBV 0/1

Price to book (2.3x) is above the industry median (1.1x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 160.0, limit 22.5).

PEG 0/1

PEG on 5-year earnings growth is 15.12, above 1.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Biogena Group Invest AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Biogena Group Invest AG

Biogena Group Invest AG engages in the provision of dietary supplements. The company is based in Salzburg, Austria.

Full company profile